Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
American Society of Nephrology to hold virtual annual meeting » 04:55
10/25/20
10/25
04:55
10/25/20
04:55
AKBA

Akebia

$3.18 /

-0.065 (-2.01%)

, ALNY

Alnylam

$131.62 /

-2.7 (-2.01%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

, AMGN

Amgen

$227.06 /

-0.84 (-0.37%)

, AZN

AstraZeneca

$52.01 /

+0.03 (+0.06%)

, BAX

Baxter

$81.08 /

-0.35 (-0.43%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BD

Budget Group

$0.00 /

+ (+0.00%)

, CALT

Calliditas Therapeutics

$26.00 /

-1.16 (-4.27%)

, ICUI

ICU Medical

$192.47 /

-2.01 (-1.03%)

, TCDA

Tricida

$8.74 /

-0.17 (-1.91%)

, SNY

Sanofi

$49.33 /

+0.39 (+0.80%)

, GSK

GlaxoSmithKline

$35.30 /

+0.22 (+0.63%)

, FOLD

Amicus

$18.48 /

+0.455 (+2.52%)

, FMS

Fresenius Medical

$40.87 /

+0.75 (+1.87%)

, DRNA

Dicerna

$19.38 /

-0.32 (-1.62%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, CCXI

ChemoCentryx

$58.92 /

+3.93 (+7.15%)

, KDNY

Chinook Therapeutics

$15.34 /

-0.1 (-0.65%)

, RTRX

Retrophin

$20.91 /

-0.12 (-0.57%)

, OMER

Omeros

$10.66 /

-0.4 (-3.62%)

, OM

Outset Medical

$50.00 /

+1.8 (+3.73%)

, NVS

Novartis

$84.41 /

-0.04 (-0.05%)

, VRTX

Vertex Pharmaceuticals

$211.52 /

+1.34 (+0.64%)

Kidney Week 2020: Virtual…

Kidney Week 2020: Virtual Annual Meeting will be held on October 19-25. Webcast Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

TCDA Tricida
$8.74 /

-0.17 (-1.91%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

RTRX Retrophin
$20.91 /

-0.12 (-0.57%)

OMER Omeros
$10.66 /

-0.4 (-3.62%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

KDNY Chinook Therapeutics
$15.34 /

-0.1 (-0.65%)

ICUI ICU Medical
$192.47 /

-2.01 (-1.03%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

FOLD Amicus
$18.48 /

+0.455 (+2.52%)

FMS Fresenius Medical
$40.87 /

+0.75 (+1.87%)

DRNA Dicerna
$19.38 /

-0.32 (-1.62%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.08 /

-0.35 (-0.43%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

10/23/20 Piper Sandler
Akebia rally justified as vadadustat has chance, says Piper Sandler
10/23/20 JPMorgan
JPMorgan says Akebia's data 'do little' to restore confidence in NDD approval
09/04/20 RBC Capital
Akebia price target lowered to $5 from $12 at RBC Capital
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
BAX Baxter
$81.08 /

-0.35 (-0.43%)

10/08/20 Goldman Sachs
Baxter pump delays speak more to FDA protocols than actual product, says Goldman
10/08/20 Piper Sandler
Baxter 510k submission withdrawal 'disappointing,' 'not surprising,' says Piper
10/08/20 KeyBanc
Investors will view Baxter pump news 'somewhat negatively,' says KeyBanc
10/01/20
Fly Intel: Top five analyst upgrades
BAYRY Bayer
$0.00 /

+ (+0.00%)

10/21/20 Morgan Stanley
Bayer price target lowered to EUR 68 from EUR 82 at Morgan Stanley
10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
BD Budget Group
$0.00 /

+ (+0.00%)

CALT Calliditas Therapeutics
$26.00 /

-1.16 (-4.27%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
ICUI ICU Medical
$192.47 /

-2.01 (-1.03%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
03/18/20 KeyBanc
ICU Medical upgraded to Overweight from Sector Weight at KeyBanc
11/12/19 Raymond James
ICU Medical price target raised to $203 from $185 at Raymond James
TCDA Tricida
$8.74 /

-0.17 (-1.91%)

09/29/20 JPMorgan
Tricida resumed with an Underweight at JPMorgan
08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Needham
Tricida price target lowered to $20 from $44 at Needham
08/25/20 Goldman Sachs
Tricida downgraded to Neutral from Buy at Goldman Sachs
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
FOLD Amicus
$18.48 /

+0.455 (+2.52%)

08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
FMS Fresenius Medical
$40.87 /

+0.75 (+1.87%)

10/13/20 Deutsche Bank
Fresenius Medical price target lowered to EUR 97 from EUR 100 at Deutsche Bank
08/18/20 Morgan Stanley
Fresenius Medical price target raised to EUR 76 from EUR 70 at Morgan Stanley
08/05/20 Jefferies
Fresenius Medical downgraded to Hold from Buy at Jefferies
07/28/20 Berenberg
Fresenius Medical price target raised to EUR 94.85 from EUR 88.25 at Berenberg
DRNA Dicerna
$19.38 /

-0.32 (-1.62%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

09/17/20 H.C. Wainwright
ChemoCentryx price target raised to $85 from $73 at H.C. Wainwright
09/17/20 Piper Sandler
ChemoCentryx target lowered to $67 at Piper Sandler on lower avacopan AAV sales
08/12/20 SVB Leerink
ChemoCentryx price target raised to $75 from $65 at SVB Leerink
07/09/20 Piper Sandler
ChemoCentryx submits NDA for avacopan in AAV to FDA, says Piper Sandler
KDNY Chinook Therapeutics
$15.34 /

-0.1 (-0.65%)

10/20/20 Oppenheimer
Chinook Therapeutics upgraded to Outperform from Perform at Oppenheimer
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
RTRX Retrophin
$20.91 /

-0.12 (-0.57%)

09/17/20 Wedbush
Wedbush starts Retrophin at Outperform ahead of 'value-creating catalysts'
09/17/20 Wedbush
Retrophin initiated with an Outperform at Wedbush
08/24/20 BofA
Retrophin initiated with a Buy at BofA
07/13/20 BMO Capital
Retrophin price target lowered to $31 from $34 at BMO Capital
OMER Omeros
$10.66 /

-0.4 (-3.62%)

10/20/20 BofA
Omeros initiated with a Buy at BofA
10/20/20 BofA
Omeros initiated with a Buy at BofA
09/01/20 Wedbush
Omeros price target lowered to $12 from $17 at Wedbush
08/21/20 H.C. Wainwright
Omeros price target lowered to $32 from $34 at H.C. Wainwright
OM Outset Medical
$50.00 /

+1.8 (+3.73%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
NVS Novartis
$84.41 /

-0.04 (-0.05%)

09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

10/15/20 Truist
Vertex Pharmaceuticals price target lowered to $305 from $330 at Truist
10/15/20 Morgan Stanley
VX-814 discontinuation can drive Vertex shares 5%-10% lower, says Morgan Stanley
10/15/20 JPMorgan
Vertex pipeline setback a 'major disappointment,' says JPMorgan
10/15/20 Citi
Vertex selloff on VX-814 news a buying opportunity, says Citi
VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

TCDA Tricida
$8.74 /

-0.17 (-1.91%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

RTRX Retrophin
$20.91 /

-0.12 (-0.57%)

OMER Omeros
$10.66 /

-0.4 (-3.62%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

ICUI ICU Medical
$192.47 /

-2.01 (-1.03%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

FOLD Amicus
$18.48 /

+0.455 (+2.52%)

DRNA Dicerna
$19.38 /

-0.32 (-1.62%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.08 /

-0.35 (-0.43%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

  • 15
    Sep
  • 12
    Aug
  • 11
    Jun
  • 09
    Jun
  • 05
    Jun
  • 12
    May
  • 05
    Dec
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

FOLD Amicus
$18.48 /

+0.455 (+2.52%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

TCDA Tricida
$8.74 /

-0.17 (-1.91%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

OMER Omeros
$10.66 /

-0.4 (-3.62%)

OM Outset Medical
$50.00 /

+1.8 (+3.73%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

CALT Calliditas Therapeutics
$26.00 /

-1.16 (-4.27%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.08 /

-0.35 (-0.43%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

KDNY Chinook Therapeutics
$15.34 /

-0.1 (-0.65%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

Yesterday
Conference/Events
American Society of Nephrology to hold virtual annual meeting » 04:55
10/24/20
10/24
04:55
10/24/20
04:55
AKBA

Akebia

$3.18 /

-0.065 (-2.01%)

, ALNY

Alnylam

$131.62 /

-2.7 (-2.01%)

, ALPMY

Astellas Pharma

$0.00 /

+ (+0.00%)

, AMGN

Amgen

$227.06 /

-0.84 (-0.37%)

, AZN

AstraZeneca

$52.01 /

+0.03 (+0.06%)

, BAX

Baxter

$81.08 /

-0.35 (-0.43%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BD

Budget Group

$0.00 /

+ (+0.00%)

, CALT

Calliditas Therapeutics

$26.00 /

-1.16 (-4.27%)

, ICUI

ICU Medical

$192.47 /

-2.01 (-1.03%)

, TCDA

Tricida

$8.74 /

-0.17 (-1.91%)

, SNY

Sanofi

$49.33 /

+0.39 (+0.80%)

, GSK

GlaxoSmithKline

$35.30 /

+0.22 (+0.63%)

, FOLD

Amicus

$18.48 /

+0.455 (+2.52%)

, FMS

Fresenius Medical

$40.87 /

+0.75 (+1.87%)

, DRNA

Dicerna

$19.38 /

-0.32 (-1.62%)

, DNA

Bought by RHHBY

$0.00 /

+ (+0.00%)

, CCXI

ChemoCentryx

$58.92 /

+3.93 (+7.15%)

, KDNY

Chinook Therapeutics

$15.34 /

-0.1 (-0.65%)

, RTRX

Retrophin

$20.91 /

-0.12 (-0.57%)

, OMER

Omeros

$10.66 /

-0.4 (-3.62%)

, OM

Outset Medical

$50.00 /

+1.8 (+3.73%)

, NVS

Novartis

$84.41 /

-0.04 (-0.05%)

, VRTX

Vertex Pharmaceuticals

$211.52 /

+1.34 (+0.64%)

Kidney Week 2020: Virtual…

Kidney Week 2020: Virtual Annual Meeting will be held on October 19-25. Webcast Link

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

TCDA Tricida
$8.74 /

-0.17 (-1.91%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

RTRX Retrophin
$20.91 /

-0.12 (-0.57%)

OMER Omeros
$10.66 /

-0.4 (-3.62%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

KDNY Chinook Therapeutics
$15.34 /

-0.1 (-0.65%)

ICUI ICU Medical
$192.47 /

-2.01 (-1.03%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

FOLD Amicus
$18.48 /

+0.455 (+2.52%)

FMS Fresenius Medical
$40.87 /

+0.75 (+1.87%)

DRNA Dicerna
$19.38 /

-0.32 (-1.62%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.08 /

-0.35 (-0.43%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

10/23/20 Piper Sandler
Akebia rally justified as vadadustat has chance, says Piper Sandler
10/23/20 JPMorgan
JPMorgan says Akebia's data 'do little' to restore confidence in NDD approval
09/04/20 RBC Capital
Akebia price target lowered to $5 from $12 at RBC Capital
09/04/20 Stifel
FibroGen's roxadustat can be 'dominant leader' as competitor fades, says Stifel
ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

09/30/20 Berenberg
Alnylam reinitiated with a Hold at Berenberg
09/08/20 Citi
Alnylam initiated with a Buy at Citi
08/11/20 Oppenheimer
Alnylam downgraded to Perform on valuation at Oppenheimer
08/11/20 Oppenheimer
Alnylam downgraded to Perform from Outperform at Oppenheimer
ALPMY Astellas Pharma
$0.00 /

+ (+0.00%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy on raised PADCEV estimates at Goldman Sachs
05/26/20 Goldman Sachs
Astellas Pharma upgraded to Buy from Neutral at Goldman Sachs
01/23/20 Morgan Stanley
Astellas Pharma resumed with an Overweight at Morgan Stanley
AMGN Amgen
$227.06 /

-0.84 (-0.37%)

10/22/20 Oppenheimer
Amgen price target lowered to $275 from $280 at Oppenheimer
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Truist
Amgen downgraded to Hold from Buy at Truist
10/09/20 Bernstein
Amgen downgraded to Market Perform from Outperform at Bernstein
AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
10/08/20 JPMorgan
AstraZeneca FY20 guide could look conservative after Q3 results, says JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/29/20 Berenberg
AstraZeneca initiated with a Buy at Berenberg
BAX Baxter
$81.08 /

-0.35 (-0.43%)

10/08/20 Goldman Sachs
Baxter pump delays speak more to FDA protocols than actual product, says Goldman
10/08/20 Piper Sandler
Baxter 510k submission withdrawal 'disappointing,' 'not surprising,' says Piper
10/08/20 KeyBanc
Investors will view Baxter pump news 'somewhat negatively,' says KeyBanc
10/01/20
Fly Intel: Top five analyst upgrades
BAYRY Bayer
$0.00 /

+ (+0.00%)

10/21/20 Morgan Stanley
Bayer price target lowered to EUR 68 from EUR 82 at Morgan Stanley
10/13/20 Barclays
Bayer downgraded to Equal Weight from Overweight at Barclays
10/08/20 Kepler Cheuvreux
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
10/05/20 UBS
Bayer price target lowered to EUR 85 from EUR 110 at UBS
BD Budget Group
$0.00 /

+ (+0.00%)

CALT Calliditas Therapeutics
$26.00 /

-1.16 (-4.27%)

07/01/20 Citi
Calliditas Therapeutics initiated with a Buy at Citi
06/30/20 Jefferies
Calliditas Therapeutics initiated with a Buy at Jefferies
06/30/20 Stifel
Calliditas Therapeutics initiated with a Buy at Stifel
ICUI ICU Medical
$192.47 /

-2.01 (-1.03%)

09/02/20 KeyBanc
ICU Medical price target raised to $218 from $199 at KeyBanc
05/13/20 KeyBanc
ICU Medical price target lowered to $199 from $206 at KeyBanc
03/18/20 KeyBanc
ICU Medical upgraded to Overweight from Sector Weight at KeyBanc
11/12/19 Raymond James
ICU Medical price target raised to $203 from $185 at Raymond James
TCDA Tricida
$8.74 /

-0.17 (-1.91%)

09/29/20 JPMorgan
Tricida resumed with an Underweight at JPMorgan
08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Needham
Tricida price target lowered to $20 from $44 at Needham
08/25/20 Goldman Sachs
Tricida downgraded to Neutral from Buy at Goldman Sachs
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
09/29/20 Berenberg
Sanofi initiated with a Hold at Berenberg
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

10/15/20 SVB Leerink
SVB Leerink sees possible opportunity for Amarin to 'salvage Vascepa' in U.S.
10/12/20 UBS
GlaxoSmithKline price target lowered to 1,730 GBp from 1,800 GBp at UBS
10/09/20 Morgan Stanley
GlaxoSmithKline price target lowered to 1,695 GBp from 1,700 GBp at Morgan Stanley
10/08/20 JPMorgan
JPMorgan backs Neutral on GSK ahead of Q3 results
FOLD Amicus
$18.48 /

+0.455 (+2.52%)

08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
06/16/20 BTIG
Amicus initiated with a Buy at BTIG
06/16/20 H.C. Wainwright
Amicus has positive read from Sanofi COMET data, says H.C. Wainwright
06/09/20 Citi
Amicus shares worth $10 on Galafold alone, says Citi
FMS Fresenius Medical
$40.87 /

+0.75 (+1.87%)

10/13/20 Deutsche Bank
Fresenius Medical price target lowered to EUR 97 from EUR 100 at Deutsche Bank
08/18/20 Morgan Stanley
Fresenius Medical price target raised to EUR 76 from EUR 70 at Morgan Stanley
08/05/20 Jefferies
Fresenius Medical downgraded to Hold from Buy at Jefferies
07/28/20 Berenberg
Fresenius Medical price target raised to EUR 94.85 from EUR 88.25 at Berenberg
DRNA Dicerna
$19.38 /

-0.32 (-1.62%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
DNA Bought by RHHBY
$0.00 /

+ (+0.00%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

09/17/20 H.C. Wainwright
ChemoCentryx price target raised to $85 from $73 at H.C. Wainwright
09/17/20 Piper Sandler
ChemoCentryx target lowered to $67 at Piper Sandler on lower avacopan AAV sales
08/12/20 SVB Leerink
ChemoCentryx price target raised to $75 from $65 at SVB Leerink
07/09/20 Piper Sandler
ChemoCentryx submits NDA for avacopan in AAV to FDA, says Piper Sandler
KDNY Chinook Therapeutics
$15.34 /

-0.1 (-0.65%)

10/20/20 Oppenheimer
Chinook Therapeutics upgraded to Outperform from Perform at Oppenheimer
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
10/07/20 SVB Leerink
Chinook Therapeutics initiated with an Outperform at SVB Leerink
RTRX Retrophin
$20.91 /

-0.12 (-0.57%)

09/17/20 Wedbush
Wedbush starts Retrophin at Outperform ahead of 'value-creating catalysts'
09/17/20 Wedbush
Retrophin initiated with an Outperform at Wedbush
08/24/20 BofA
Retrophin initiated with a Buy at BofA
07/13/20 BMO Capital
Retrophin price target lowered to $31 from $34 at BMO Capital
OMER Omeros
$10.66 /

-0.4 (-3.62%)

10/20/20 BofA
Omeros initiated with a Buy at BofA
10/20/20 BofA
Omeros initiated with a Buy at BofA
09/01/20 Wedbush
Omeros price target lowered to $12 from $17 at Wedbush
08/21/20 H.C. Wainwright
Omeros price target lowered to $32 from $34 at H.C. Wainwright
OM Outset Medical
$50.00 /

+1.8 (+3.73%)

10/12/20
Fly Intel: Top five analyst initiations
10/12/20 Morgan Stanley
Outset Medical initiated with an Equal Weight at Morgan Stanley
10/12/20 Stifel
Outset Medical initiated with a Buy at Stifel
10/12/20 SVB Leerink
Outset Medical initiated with a Market Perform at SVB Leerink
NVS Novartis
$84.41 /

-0.04 (-0.05%)

09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

10/15/20 Truist
Vertex Pharmaceuticals price target lowered to $305 from $330 at Truist
10/15/20 Morgan Stanley
VX-814 discontinuation can drive Vertex shares 5%-10% lower, says Morgan Stanley
10/15/20 JPMorgan
Vertex pipeline setback a 'major disappointment,' says JPMorgan
10/15/20 Citi
Vertex selloff on VX-814 news a buying opportunity, says Citi
VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

TCDA Tricida
$8.74 /

-0.17 (-1.91%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

RTRX Retrophin
$20.91 /

-0.12 (-0.57%)

OMER Omeros
$10.66 /

-0.4 (-3.62%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

ICUI ICU Medical
$192.47 /

-2.01 (-1.03%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

FOLD Amicus
$18.48 /

+0.455 (+2.52%)

DRNA Dicerna
$19.38 /

-0.32 (-1.62%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.08 /

-0.35 (-0.43%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

  • 15
    Sep
  • 12
    Aug
  • 11
    Jun
  • 09
    Jun
  • 05
    Jun
  • 12
    May
  • 05
    Dec
SNY Sanofi
$49.33 /

+0.39 (+0.80%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

FOLD Amicus
$18.48 /

+0.455 (+2.52%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

TCDA Tricida
$8.74 /

-0.17 (-1.91%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

OMER Omeros
$10.66 /

-0.4 (-3.62%)

OM Outset Medical
$50.00 /

+1.8 (+3.73%)

NVS Novartis
$84.41 /

-0.04 (-0.05%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

CCXI ChemoCentryx
$58.92 /

+3.93 (+7.15%)

CALT Calliditas Therapeutics
$26.00 /

-1.16 (-4.27%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

BAX Baxter
$81.08 /

-0.35 (-0.43%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

ALNY Alnylam
$131.62 /

-2.7 (-2.01%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

VRTX Vertex Pharmaceuticals
$211.52 /

+1.34 (+0.64%)

SNY Sanofi
$49.33 /

+0.39 (+0.80%)

KDNY Chinook Therapeutics
$15.34 /

-0.1 (-0.65%)

GSK GlaxoSmithKline
$35.30 /

+0.22 (+0.63%)

AZN AstraZeneca
$52.01 /

+0.03 (+0.06%)

AMGN Amgen
$227.06 /

-0.84 (-0.37%)

AKBA Akebia
$3.18 /

-0.065 (-2.01%)

Friday
Hot Stocks
Baker Hughes reports U.S. rig count up 5 to 287 rigs » 13:06
10/23/20
10/23
13:06
10/23/20
13:06
BKR

Baker Hughes

$14.26 /

-0.19 (-1.31%)

Baker Hughes reports that…

Baker Hughes reports that the U.S. rig count is up 5 from last week to 287 with oil rigs up 6 to 211, gas rigs down 1 to 73, and miscellaneous rigs unchanged at 3. The U.S. Rig Count is down 543 rigs from last year's count of 830, with oil rigs down 485, gas rigs down 60 and miscellaneous rigs up 2. The U.S. Offshore Rig Count is down 1 to 13, down 8 year-over-year. The Canada Rig Count is up 3 from last week to 83, with oil rigs up 2 to 42, gas rigs up 1 to 41. The Canada Rig Count is down 64 rigs from last year's count of 147, with oil rigs down 60, gas rigs down 4.

ShowHide Related Items >><<
BKR Baker Hughes
$14.26 /

-0.19 (-1.31%)

BKR Baker Hughes
$14.26 /

-0.19 (-1.31%)

10/12/20 Exane BNP Paribas
Baker Hughes initiated with an Outperform at Exane BNP Paribas
10/01/20 BMO Capital
Baker Hughes initiated with a Market Perform at BMO Capital
08/13/20
Fly Intel: Top five analyst downgrades
08/13/20 Goldman Sachs
Baker Hughes downgraded to Buy from Conviction Buy at Goldman Sachs
BKR Baker Hughes
$14.26 /

-0.19 (-1.31%)

BKR Baker Hughes
$14.26 /

-0.19 (-1.31%)

BKR Baker Hughes
$14.26 /

-0.19 (-1.31%)

Recommendations
Unilever price target raised to EUR 43 from EUR 42 at RBC Capital » 11:40
10/23/20
10/23
11:40
10/23/20
11:40
UN

Unilever

$60.44 /

-0.28 (-0.46%)

RBC Capital analyst James…

RBC Capital analyst James Edwardes Jones raised the firm's price target on Unilever to EUR 43 from EUR 42 and keeps an Underperform rating on the shares.

ShowHide Related Items >><<
UN Unilever
$60.44 /

-0.28 (-0.46%)

UN Unilever
$60.44 /

-0.28 (-0.46%)

10/23/20 Investec
Unilever downgraded to Hold from Buy at Investec
10/19/20 Deutsche Bank
Unilever resumed with a Buy at Deutsche Bank
10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 Exane BNP Paribas
Unilever upgraded to Outperform from Neutral at Exane BNP Paribas
UN Unilever
$60.44 /

-0.28 (-0.46%)

UN Unilever
$60.44 /

-0.28 (-0.46%)

Recommendations
AkzoNobel price target raised to EUR 102 from EUR 96 at Societe Generale » 11:05
10/23/20
10/23
11:05
10/23/20
11:05
AKZOY

AkzoNobel

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Societe Generale analyst Peter Clark raised the firm's price target on AkzoNobel to EUR 102 from EUR 96 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
AKZOY AkzoNobel
$0.00 /

+ (+0.00%)

10/22/20 Deutsche Bank
AkzoNobel price target raised to EUR 102 from EUR 100 at Deutsche Bank
09/23/20 Morgan Stanley
AkzoNobel price target raised to EUR 112 from EUR 105 at Morgan Stanley
09/14/20 JPMorgan
AkzoNobel price target raised to EUR 90 from EUR 78 at JPMorgan
08/11/20 Barclays
AkzoNobel price target raised to EUR 96 from EUR 95 at Barclays
Hot Stocks
EU commercial vehicle registrations up 13.3% in September » 07:35
10/23/20
10/23
07:35
10/23/20
07:35
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

, PCAR

Paccar

$91.70 /

+0.73 (+0.80%)

, CNHI

CNH Industrial

$8.50 /

-0.04 (-0.47%)

, NAV

Navistar

$43.13 /

-0.16 (-0.37%)

, CMI

Cummins

$223.54 /

+1.33 (+0.60%)

, ALSN

Allison Transmission

$38.77 /

+0.63 (+1.65%)

In September, demand for…

In September, demand for commercial vehicles in the European Union improved markedly, reported the European Automobile Manufacturers Association. Registrations across the EU increased by 13.3% to 163,512 units last month. This growth was largely driven by the van segment, which accounted for over 84% of all CV registrations, the group said. Publicly traded truck makers and suppliers include Daimler AG (DDAIF), Paccar (PCAR), CNH Industrial (CNHI), Navistar (NAV), Cummins (CMI) and Allison Transmission (ALSN).

ShowHide Related Items >><<
PCAR Paccar
$91.70 /

+0.73 (+0.80%)

NAV Navistar
$43.13 /

-0.16 (-0.37%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

CNHI CNH Industrial
$8.50 /

-0.04 (-0.47%)

CMI Cummins
$223.54 /

+1.33 (+0.60%)

ALSN Allison Transmission
$38.77 /

+0.63 (+1.65%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Daimler AG price target raised to EUR 58 from EUR 55 at Morgan Stanley
10/16/20 Pareto
Daimler AG upgraded to Hold from Sell at Pareto
10/15/20 UBS
Daimler AG price target raised to EUR 50 from EUR 41 at UBS
10/13/20 Citi
Daimler AG price target raised to EUR 50 at Citi
PCAR Paccar
$91.70 /

+0.73 (+0.80%)

10/22/20 Argus
Paccar upgraded to Buy from Hold at Argus
10/22/20 Argus
Paccar upgraded to Buy from Hold at Argus
10/21/20 BMO Capital
Paccar price target raised to $90 from $80 at BMO Capital
10/13/20 JPMorgan
Paccar downgraded to Neutral on balanced risk/reward at JPMorgan
CNHI CNH Industrial
$8.50 /

-0.04 (-0.47%)

09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
08/13/20 JPMorgan
JPMorgan downgrades Deere and Oshkosh amid U.S. Machinery ratings reshuffle
08/13/20 JPMorgan
CNH Industrial upgraded to Overweight from Neutral at JPMorgan
07/23/20 OTR Global
Farm Equipment Manufacturers upgraded to Mixed from Negative at OTR Global
NAV Navistar
$43.13 /

-0.16 (-0.37%)

10/23/20 Jefferies
Navistar downgraded to Hold from Buy at Jefferies
10/14/20 Loop Capital
Navistar downgraded to Hold from Buy at Loop Capital
09/15/20 UBS
Navistar price target raised to $43 from $29 at UBS
09/15/20 BMO Capital
Navistar price target raised to $43 from $35 at BMO Capital
CMI Cummins
$223.54 /

+1.33 (+0.60%)

10/19/20 Baird
Cummins reinstated with a Neutral at Baird
10/16/20 Citi
Cummins price target raised to $250 from $215 at Citi
10/13/20 Deutsche Bank
Cummins price target raised to $221 from $202 at Deutsche Bank
10/05/20 JPMorgan
Class 8 truck orders rose 145% in September, says JPMorgan
ALSN Allison Transmission
$38.77 /

+0.63 (+1.65%)

10/19/20 Baird
Allison Transmission reinstated with a Neutral at Baird
10/19/20 Baird
Allison Transmission reinstated with a Neutral at Baird
10/16/20 Citi
Citi opens 'positive catalyst watch' on Allison Transmission, ups target
PCAR Paccar
$91.70 /

+0.73 (+0.80%)

NAV Navistar
$43.13 /

-0.16 (-0.37%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

CNHI CNH Industrial
$8.50 /

-0.04 (-0.47%)

CMI Cummins
$223.54 /

+1.33 (+0.60%)

ALSN Allison Transmission
$38.77 /

+0.63 (+1.65%)

NAV Navistar
$43.13 /

-0.16 (-0.37%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

NAV Navistar
$43.13 /

-0.16 (-0.37%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

CNHI CNH Industrial
$8.50 /

-0.04 (-0.47%)

NAV Navistar
$43.13 /

-0.16 (-0.37%)

CMI Cummins
$223.54 /

+1.33 (+0.60%)

Hot Stocks
Daimler AG sees 2020 Group EBIT at the level of the prior year » 06:28
10/23/20
10/23
06:28
10/23/20
06:28
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

Daimler previously said…

Daimler previously said it expected Group EBIT to be "positive in 2020, but lower than in the previous year."

ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Daimler AG price target raised to EUR 58 from EUR 55 at Morgan Stanley
10/16/20 Pareto
Daimler AG upgraded to Hold from Sell at Pareto
10/15/20 UBS
Daimler AG price target raised to EUR 50 from EUR 41 at UBS
10/13/20 Citi
Daimler AG price target raised to EUR 50 at Citi
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Hot Stocks
Daimler AG sees 2020 group revenue, total unit sales below last year » 06:27
10/23/20
10/23
06:27
10/23/20
06:27
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

Daimler said:…

Daimler said: "Daimler assumes that economic conditions in the most important markets continue to normalize and in particular that no further setbacks occur as a result of the COVID-19 pandemic. Based on this, Daimler expects that the significant unit-sales reductions recorded in the first nine months due to the COVID-19 pandemic will only be partially offset by the end of the year. The company therefore expects Group unit sales and Group revenue in 2020 to be significantly lower than in the previous year. On the basis of the expected market development and the current assessments of the divisions, Daimler anticipates Group EBIT in 2020 at the level of the prior year."

ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Daimler AG price target raised to EUR 58 from EUR 55 at Morgan Stanley
10/16/20 Pareto
Daimler AG upgraded to Hold from Sell at Pareto
10/15/20 UBS
Daimler AG price target raised to EUR 50 from EUR 41 at UBS
10/13/20 Citi
Daimler AG price target raised to EUR 50 at Citi
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Hot Stocks
Daimler AG reports Q3 group sales 772,700 units vs. 839,300 units last year  06:26
10/23/20
10/23
06:26
10/23/20
06:26
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Daimler AG price target raised to EUR 58 from EUR 55 at Morgan Stanley
10/16/20 Pareto
Daimler AG upgraded to Hold from Sell at Pareto
10/15/20 UBS
Daimler AG price target raised to EUR 50 from EUR 41 at UBS
10/13/20 Citi
Daimler AG price target raised to EUR 50 at Citi
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Earnings
Daimler AG reports Q3 EPS EUR 1.92 vs. EUR 1.61 last year » 06:26
10/23/20
10/23
06:26
10/23/20
06:26
DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

Reports Q3 revenue EUR…

Reports Q3 revenue EUR 40.28B vs. EUR 43.27B last year. Reports Q3 EBIT EUR 3.07B vs. EUR 2.69B last year. The key figures reflect a good performance based on improving markets and strong products, combined with diligent cost discipline and extensive cash-preservation measures, the company said.

ShowHide Related Items >><<
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

10/20/20 Morgan Stanley
Daimler AG price target raised to EUR 58 from EUR 55 at Morgan Stanley
10/16/20 Pareto
Daimler AG upgraded to Hold from Sell at Pareto
10/15/20 UBS
Daimler AG price target raised to EUR 50 from EUR 41 at UBS
10/13/20 Citi
Daimler AG price target raised to EUR 50 at Citi
DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

DDAIF Daimler AG
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.